MedPath

北京锐业制药有限公司

Ownership
-
Established
1999-05-20
Employees
-
Market Cap
-
Website
http://www.ruiyezhiyao.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

NMPA:18

Drug Approvals

Cefuroxime Sodium for Injection and Sodium Chloride Injection

Product Name
注射用头孢呋辛钠/氯化钠注射液
Approval Number
国药准字H20193161
Approval Date
Jun 4, 2024
NMPA

Cefuroxime Sodium for Injection and Soudium Chloride Injection

Product Name
注射用头孢呋辛钠/氯化钠注射液
Approval Number
国药准字H20217060
Approval Date
Jun 4, 2024
NMPA

Cefodizime Sodium for Injection and Sodium Chloride Injection

Product Name
注射用头孢地嗪钠/氯化钠注射液
Approval Number
国药准字H20193157
Approval Date
May 28, 2024
NMPA

Cefodizime Sodium for Injection and 5% Glucose Injection

Product Name
注射用头孢地嗪钠/5%葡萄糖注射液
Approval Number
国药准字H20193156
Approval Date
May 28, 2024
NMPA

Cefodizime Sodium for Injection and Sodium Chloride Injection

Product Name
注射用头孢地嗪钠/氯化钠注射液
Approval Number
国药准字H20193158
Approval Date
May 28, 2024
NMPA

Cefodizime Sodium for Injection and 5% Glucose Injection

Product Name
注射用头孢地嗪钠/5%葡萄糖注射液
Approval Number
国药准字H20193155
Approval Date
May 28, 2024
NMPA

Ceftazidime for Injection and Sodium Chloride Injection

Product Name
注射用头孢他啶/氯化钠注射液
Approval Number
国药准字H20193106
Approval Date
Apr 23, 2024
NMPA

Ceftazidime for Injection and Sodium Chloride Injection

Product Name
注射用头孢他啶/氯化钠注射液
Approval Number
国药准字H20205047
Approval Date
Apr 23, 2024
NMPA

Cefepime Hydrochloride for Injection and Sodium Chloride Injection

Product Name
注射用盐酸头孢吡肟/氯化钠注射液
Approval Number
国药准字H20234019
Approval Date
Aug 8, 2023
NMPA

Cefepime Hydrochloride for Injection and Sodium Chloride Injection

Product Name
注射用盐酸头孢吡肟/氯化钠注射液
Approval Number
国药准字H20234018
Approval Date
Aug 8, 2023
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.